Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
24 results
D2.480 - Features of the molecular sensitization profile in children with autism spectrum disorder
D2.485 - Comprehensive Understanding of the Characteristics of Pediatric Pollen Allergy Patients
D2.486 - Levels of house dust mite in dust settlements are associated with risk for allergic rhinitis in children
D2.479 - The bullous pemphigoid in a baby
D2.481 - Severe obstructive syndrome in children with bronchopulmonary malformations
D2.488 - Functional confirmation of exercise-induced bronchoconstriction in children: A three-year retrospective study
D3.51 - Cardiovascular System Problems in Children Athletes with Allergic Diseases
D3.59 - Occupational Cobalt Contact Dermatitis: Clinical Profile and Work implications
D3.52 - Clinical spectrum and diagnostic challenges of paediatric angioedema without wheals
D3.55 - Hereditary angioedema with normal C1-INH: DAB2IP mutation report
D3.56 - Investigation of Serum Eosinophilic Granule Proteins Levels in Children with Chronic Spontaneous Urticaria
D3.58 - Eosinophilic ascites and extreme hypereosinophilia: differential diagnosis through medical treatment
D3.60 - Allergic reaction in bisoprolol overdose
D3.61 - Acquired Food Allergy After Allogeneic Hematopoietic Stem Cell Transplantation From a Non-Allergic Unrelated Donor
D3.62 - Application of a logistic regression model to predict the risk of allergic reactions in children with salmon sensitization (Sal s 1)
D3.50 - Molecular Characterization of Allergen Sensitization and Clinical Associations in a Romanian Cohort Using ALEX² Multiplex Assay
D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset
D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study
D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes
D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download